ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has reported Gross Margin for 3 consecutive years, with 100.0% the latest figure, recorded in Q1 2018.

• On a quarterly basis, Gross Margin changed N/A year-over-year to 100.0% in Q1 2018; TTM through Dec 2018 was 100.0%, a 4914.0% increase from a year earlier, with the FY2018 full-year figure at 100.0%, up 4914.0% from the prior year.
• Gross Margin was 100.0% for Q1 2018 at ENDRA Life Sciences, up from 54.96% in the prior quarter.
• Over five years, Gross Margin peaked at 100.0% in Q1 2018 and troughed at 10.98% in Q2 2017.
• A 3-year average of 55.8% and a median of 54.96% in 2017 frame the typical range for Gross Margin.
• The widest YoY moves for Gross Margin: up 71 bps in 2017, down 71 bps in 2017.
• Over 3 years, Gross Margin stood at 54.25% in 2016, then climbed by 1 bps to 54.96% in 2017, then jumped by 82 bps to 100.0% in 2018.
• The last three Gross Margin figures came in at 100.0% (Q1 2018), 54.96% (Q4 2017), and 58.79% (Q3 2017), per Business Quant data.